Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Ltd Share Price Today: Live Updates & Key Insights

Get insights on Kilitch Drugs (India) Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Kilitch Drugs (India) Ltd Share Price Chart

Kilitch Drugs (India) Ltd Fundamentals

Traded Volume: 26,112

Market Cap(Cr): 645

Avg Traded Price 366.23

1 Year return 23.09%

Upper Circuit 372

Lower Circuit 356.6

P/E TTM 23.00

P/B Ratio 16.00

Traded Value(Cr) 96.27

EPS TTM 15.775

Book value 15.775

Dividend 0.00%

Kilitch Drugs (India) Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Kilitch Drugs (India) Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Kilitch Drugs (India) Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +0.30%

1M -0.12%

3M -11.37%

1Y +23.09%

YTD +13.31%

Kilitch Drugs (India) Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Kilitch Drugs (India) Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 29862.00

Day Before Yesterday 14942.00

1W Avg 36598.40

1M Avg 68357.86

3M Avg 31387.03

Kilitch Drugs (India) Ltd Technical Details

Kilitch Drugs (India) Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 360

Support 2 350

Support 3 344

Pivot Point : 366

Resistance 1 375

Resistance 2 381

Resistance 3 390

Kilitch Drugs (India) Ltd Corporate Actions

Kilitch Drugs (India) Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Kilitch Drugs (India) Ltd’s capital allocation strategies.

All

Ex-Date 15-Jul-2025 Type R Description /share@2:23% Record Date 15-Jul-2025 Ratio 2:23

Ex-Date 20-Sep-2019 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00

Ex-Date 18-Sep-2018 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00

Ex-Date 24-Sep-2012 Type D Description 30.00/share@300.00% Record Date 25-Sep-2012 Ratio 300.00

Ex-Date 18-Aug-2011 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00

Ex-Date 14-Oct-2010 Type D Description 1.00/share@10.00% Record Date 15-Oct-2010 Ratio 10.00

Ex-Date 10-Sep-2009 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00

Ex-Date 10-Sep-2008 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00

Ex-Date 15-Nov-2007 Type D Description 1.00/share@10.00% Record Date 16-Nov-2007 Ratio 10.00

Dividends

Announcement Date 20-Sep-2019 Ex Dividend Date 20-Sep-2019 Dividend(%) 5

Announcement Date 18-Sep-2018 Ex Dividend Date 18-Sep-2018 Dividend(%) 5

Announcement Date 24-Sep-2012 Ex Dividend Date 24-Sep-2012 Dividend(%) 300

Announcement Date 18-Aug-2011 Ex Dividend Date 18-Aug-2011 Dividend(%) 10

Announcement Date 14-Oct-2010 Ex Dividend Date 14-Oct-2010 Dividend(%) 10

Announcement Date 10-Sep-2009 Ex Dividend Date 10-Sep-2009 Dividend(%) 10

Announcement Date 10-Sep-2008 Ex Dividend Date 10-Sep-2008 Dividend(%) 10

Announcement Date 15-Nov-2007 Ex Dividend Date 15-Nov-2007 Dividend(%) 10

Bonus

No Bonus has been declared by KILITCH

Splits

No Split has been declared by KILITCH

Others

Ex-Rights Date 15-Jul-2025 Premium(Rs.) 347.00 Ratio 2:23

Kilitch Drugs (India) Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Kilitch Drugs (India) Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Kilitch Drugs (India) Ltd's relative performance and valuation against major competitors.

Stock Name Anuh Pharma Ltd ₹79.57 (-0.85%) M. Cap (Cr) 7.97 1 Yr Return (%) -16.07% P/E (TTM) 20.61 PB Ratio 2.45

Stock Name Bharat Parenterals Ltd ₹1103.35 (-1.13%) M. Cap (Cr) 7.60 1 Yr Return (%) -27.71% P/E (TTM) -140.56 PB Ratio 2.30

Stock Name Accent Microcell Ltd ₹308.20 (-2.88%) M. Cap (Cr) 7.39 1 Yr Return (%) +35.56% P/E (TTM) 22.36 PB Ratio 3.15

Stock Name Kilitch Drugs (India) Ltd ₹368.70 (+1.70%) M. Cap (Cr) 6.45 1 Yr Return (%) +23.09% P/E (TTM) 23.37 PB Ratio 2.56

Stock Name Shree Ganesh Remedies Ltd ₹490.00 (+6.99%) M. Cap (Cr) 6.29 1 Yr Return (%) -26.90% P/E (TTM) 29.73 PB Ratio 4.56

Stock Name Kopran Ltd ₹128.61 (-4.02%) M. Cap (Cr) 6.21 1 Yr Return (%) -35.55% P/E (TTM) 35.29 PB Ratio 1.20

Stock Name Jenburkt Pharmaceuticals Ltd ₹1245.00 (+0.63%) M. Cap (Cr) 5.49 1 Yr Return (%) +10.26% P/E (TTM) 16.63 PB Ratio 3.19

Kilitch Drugs (India) Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Kilitch Drugs (India) Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 15.23 Mar 2024 -1.19 Mar 2023 6.10 Mar 2022 5.20 Mar 2021 6.13

PARTICULARS Investing Activities Mar 2025 -41.42 Mar 2024 -10.10 Mar 2023 6.24 Mar 2022 -16.08 Mar 2021 -5.35

PARTICULARS Financing Activities Mar 2025 15.65 Mar 2024 11.40 Mar 2023 3.04 Mar 2022 7.55 Mar 2021 2.27

PARTICULARS Net Cash Flow Mar 2025 -10.54 Mar 2024 0.11 Mar 2023 15.39 Mar 2022 -3.32 Mar 2021 3.05

Kilitch Drugs (India) Ltd Shareholding Pattern

This shows the ownership breakdown of Kilitch Drugs (India) Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 63.77%

Public 36.22%

Other Institutions 0%

FII null%

Mutual Funds null%

About Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe. Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices.The Company is engaged in development, manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions.The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules, liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.'95 to expand the capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation. It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga, Maharashtra for producing raw materials for formulations. The company exports to Sudan, Yemen, middle-east, Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus, Bon-Bon Gripe Water and Kilitch Balm.The Company launched a new product 'BENIN' in the market in 2011. During the year 2011-12, the Company sold its business located at Paonta Sahib, Himachal Pradesh as a going concern on a slump sale basis along with transfer of services set forth in the Business Transfer Agreement (BTA). The undertaking was sold and transferred on 28th February 2012 after getting all the necessary clearances as indicated in the BTA. It retained its Name, Trademark (Kilitch) and all other properties and assets at Mumbai. It transferred certain products by entering into a Product Transfer Agreement (PTA) with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.

Chairman & Managing Director

Mukund P Mehta

Registered office C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705

FAX :91-022-27670322/27680913/65144185

Background

Incorporation Year 1992

Face Value ₹10.00

Market Lot 1

Kilitch Drugs (India) Ltd Latest News

VIEW MORE NEWS

FAQs on Kilitch Drugs (India) Ltd